Human medicines European public assessment report (EPAR): Vgenfli, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Vgenfli, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Vgenfli, aflibercept, Status: Opinion
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Status: Opinion
Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Status: Opinion
Summary of opinion: Benlysta, 19/06/2025 Positive
Summary of opinion: Sarclisa, 19/06/2025 Positive
Summary of opinion: Imbruvica, 19/06/2025 Positive
New stem cell therapy to treat patients with blood cancers
Summary of opinion: Nubeqa, 19/06/2025 Positive
Referral: Finasteride- and dutasteride-containing medicinal products, finasteride,dutasteride Article 31 referrals CMDh position, 20/06/2025
Summary of opinion: Darzalex, 19/06/2025 Positive